Univ. Of Calif., Astellas Defend Cancer Drug IP In Dutch Court
The University of California and Astellas Pharma have persuaded a Dutch court to uphold a patent covering prostate cancer drug Xtandi, marking another win in their fight to keep generic versions...To view the full article, register now.
Already a subscriber? Click here to view full article